Yield and Pitfalls of Ajmaline Testing in the Evaluation of Unexplained Cardiac Arrest and Sudden Unexplained Death: Single-Center Experience With 482 Families.

doi:10.1016/j.jacep.2017.04.005

Article

Yield and Pitfalls of Ajmaline Testing in the Evaluation of Unexplained Cardiac Arrest and Sudden Unexplained Death: Single-Center Experience With 482 Families.

JACC. Clinical electrophysiology - 11 Dec 2017

Tadros Rafik, Nannenberg Eline A, Lieve Krystien V, Škorić-Milosavljević Doris, Lahrouchi Najim, Lekanne Deprez Ronald H, Vendrik Jeroen, Reckman Yolan J, Postema Pieter G, Amin Ahmad S, Bezzina Connie R, Wilde Arthur A M, Tan Hanno L

Abstract excerpt

OBJECTIVES: This study evaluated the yield of ajmaline testing and assessed the occurrence of confounding responses in a large cohort of families with unexplained cardiac arrest (UCA) or sudden unexplained death (SUD). BACKGROUND: Ajmaline testing to diagnose Brugada syndrome (BrS) is routinely used in the evaluation of SUD and UCA, but its yield, limitations, and appropriate dosing have not been studied in a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Yield and Pitfalls of Ajmaline Testing in the Evaluation of Unexplained Cardiac Arrest and Sudden Unexplained Death: Single-Center Experience With 482 Families.

Abstract excerpt

Topics

Related research